These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26412474)

  • 1. Connections between nutritional status and proton pump inhibitor therapy in patients scheduled for cardiovascular rehabilitation after treatment for ischaemic and valvular heart disease.
    Boban M; Persic V; Petricevic M; Biocina B; Sipic T; Pehar-Pejcnovic V; Balen S; Zulj M; Vcev A
    Kardiol Pol; 2016; 74(5):461-468. PubMed ID: 26412474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiovascular treatments and systolic dysfunction on nutritional risk in patients with ischemic and valvular heart disease.
    Boban M; Persic V; Petricevic M; Manola S; Boban L; Vcev A
    J Am Coll Nutr; 2015; 34(2):159-66. PubMed ID: 25751132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of NRS-2002 Nutritional Risk Screening in patients hospitalized for secondary cardiovascular prevention and rehabilitation.
    Boban M; Laviano A; Persic V; Rotim A; Jovanovic Z; Vcev A
    J Am Coll Nutr; 2014; 33(6):466-73. PubMed ID: 25387165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart surgery stems increased nutritional risk, expressed during the course of stationary rehabilitation.
    Boban M; Persic V; Miletic B; Kovacicek K; Madzar Z
    Ann Nutr Metab; 2013; 63(1-2):17-24. PubMed ID: 23867581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity dilemma in the global burden of cardiovascular diseases.
    Boban M; Persic V; Jovanovic Z; Brozina A; Miletic B; Rotim A; Drinkovic N; Manola S; Laskarin G; Boban L
    Int J Clin Pract; 2014 Feb; 68(2):173-9. PubMed ID: 24355081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Long-Term Proton Pump Inhibitor Therapy on Nutritional Status in Elderly Hospitalized Patients.
    Nakamichi M; Wakabayashi H
    J Nutr Sci Vitaminol (Tokyo); 2016; 62(5):330-334. PubMed ID: 27928120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
    Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
    JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and seasonal variations of nutritional risk screening in patients scheduled for rehabilitation after heart surgery.
    Boban M; Persic V; Jovanovic Z; Drinkovic N; Milosevic M; Laviano A
    Heart Surg Forum; 2013 Dec; 16(6):E336-43. PubMed ID: 24370803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
    Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
    Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients.
    Kofler S; Deutsch MA; Bigdeli AK; Shvets N; Vogeser M; Mueller TH; Meiser B; Steinbeck G; Reichart B; Kaczmarek I
    J Heart Lung Transplant; 2009 Jun; 28(6):605-11. PubMed ID: 19481022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013.
    Nishtala PS; Soo L
    Intern Med J; 2015 Jun; 45(6):624-9. PubMed ID: 25828419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.